Merit Financial Group, LLC Immunity Bio, Inc. Transaction History
Merit Financial Group, LLC
- $4.59 Billion
- Q3 2024
A detailed history of Merit Financial Group, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 43,800 shares of IBRX stock, worth $213,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,800
Previous 43,819
0.04%
Holding current value
$213,306
Previous $276,000
41.3%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding IBRX
# of Institutions
200Shares Held
71.4MCall Options Held
1.01MPut Options Held
1.25M-
Vanguard Group Inc Valley Forge, PA16.9MShares$82.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$55.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$42.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$18.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$10.9 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.95B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...